FDA requires Guillain-Barre label warnings for 2 RSV vaccines
1 day ago · The US Food and Drug Administration (FDA) announced yesterday that it has required and approved labeling changes for two respiratory syncytial virus (RSV) vaccines owing to the risk of Guillain-Barre syndrome, a rare neurologic disorder. Drazen Zigic / iStock. The new labeling warnings apply to Pfizer's Abrysvo vaccine and GSK's Arexvy vaccine.
Trends of acute respiratory infection, including human …
2 days ago · In many countries of the Northern Hemisphere, trends in acute respiratory infections increase at this time of year. These increases are typically caused by seasonal epidemics of respiratory pathogens such as seasonal influenza, respiratory syncytial virus (RSV), and other common respiratory viruses, including human metapneumovirus (hMPV), as well as mycoplasma pneumoniae. Many countries ...
Nirsevimab decreased the subsequent risk of respiratory syncytial virus ...
21 hours ago · Preventing respiratory syncytial virus (RSV) infection in infants and young children is a global public health priority. 1 Long-term respiratory outcomes associated with RSV infection are ...
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
RSV is straining some hospitals, and US ... - Associated Press News
Nov 16, 2023 · RSV, or respiratory syncytial virus, is a common cause of mild cold-like symptoms such as runny nose, cough and fever. Still, it can be dangerous for infants and older people. The CDC estimates that RSV causes 100 to 300 deaths and 58,000 to 80,000 hospitalizations each year among kids aged 4 and under.
Guillain-Barre syndrome 'more common than ... - Associated Press News
May 30, 2024 · An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older people, according to the CDC.
Researchers use biophysics to design new vaccines against RSV …
Nov 19, 2024 · Now, scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. In most people, the lung-infecting pathogens known as...
Respiratory syncytial virus | AP News
Sep 29, 2023 · Respiratory syncytial virus US health officials strengthen endorsement of RSV shots for oldest Americans Federal health officials are strengthening their endorsement of RSV vaccinations for people 75 and older.
Progress at last against RSV | Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has strained...
New approach to stabilize RSV protein could lead to better vaccines
Nov 20, 2024 · Scientists have long attempted to create vaccines that coax the immune system into recognizing the fusion (F) proteins present on the surfaces of RSV, hMPV and related viruses. These proteins play...